Showing results (621-630 of 758) with videos related to

Sort By:
Pageof 76
European Journal of Medicinal Chemistry|May 14, 2020
Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/keap1 pathwayLun Wang, Xiaoying Cai, Mingsong Shi, et al.
Horticulture Research|October 14, 2022
The high-quality genome of pummelo provides insights into the tissue-specific regulation of citric acid and anthocyanin during domesticationZhihao Lu, Yue Huang, Sangyin Mao, et al.
BMJ Open|October 15, 2015
Association between low dietary zinc and hyperuricaemia in middle-aged and older males in China: a cross-sectional studyDong-xing Xie, Yi-lin Xiong, Chao Zeng, et al.
BMC Genomics|August 7, 2025
An optimized protocol for in vitro regeneration and genetic transformation of broomcorn milletZhaolan Cui, Wenmin Wei, Xinqi Han, et al.
Oncotarget|April 2, 2016
Low disabled-2 expression promotes tumor progression and determines poor survival and high recurrence of esophageal squamous cell carcinomaWen-Lun Wang, Wei-Lun Chang, Hsiao-Bai Yang, et al.
Cancer Biomarkers : Section a of Disease Markers|January 14, 2020
Development and validation of an immune prognostic classifier for clear cell renal cell carcinomaYong-Yao Gu, Gang Chen, Peng Lin, et al.
Japanese Heart Journal|September 14, 2002
Spinal epidural hematoma following tissue plasminogen activator and heparinization for acute myocardial infarctionKuei-Chuan Chan, Der-Jinn Wu, Kwo-Chang Ueng, et al.
Scientific Reports|April 24, 2020
Risk factors and pathological characteristics for intraductal tumor spread of submucosal gland in early esophageal squamous cell neoplasiaWen-Lun Wang, I-Wei Chang, Ming-Hung Hsu, et al.
Optics Express|March 14, 2013
Fluorescence enhancement in broadband Cr-doped fibers fabricated by drawing towerYi-Chung Huang, Chun-Nien Liu, Yen-Sheng Lin, et al.
Rheumatology (Oxford, England)|July 15, 2019
Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extensionRonald F van Vollenhoven, Sandra V Navarra, Roger A Levy, et al.
Pageof 76